tiprankstipranks
Kaken Pharmaceutical Co Ltd (KKPCF)
OTHER OTC:KKPCF
US Market
KKPCF
Kaken Pharmaceutical Co
RESEARCH TOOLSreports
Want to see KKPCF full AI Analyst Report?

Kaken Pharmaceutical Co (KKPCF) Financial Statements

4 Followers

Kaken Pharmaceutical Co Financial Overview

Kaken Pharmaceutical Co's market cap is currently $941.86M. The company's EPS TTM is $333.12; its P/E ratio is 73.21; and it has a dividend yield of 4.34%. Kaken Pharmaceutical Co is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 26Mar 25Mar 24Mar 23
Income Statement
Total Revenue¥ 94.03B¥ 76.87B¥ 72.04B¥ 72.98B¥ 76.03B
Gross Profit¥ 58.26B¥ 39.24B¥ 38.54B¥ 39.56B¥ 41.58B
Operating Income¥ 21.04B¥ -899.00M¥ 9.51B¥ 8.00B¥ 17.06B
EBITDA¥ 22.02B¥ 2.43B¥ 12.57B¥ 9.40B¥ 16.38B
Net Income¥ 13.95B¥ 2.14B¥ 8.03B¥ 5.44B¥ 9.55B
Balance Sheet
Cash & Short-Term Investments¥ 70.08B¥ 50.70B¥ 65.32B¥ 74.26B¥ 74.62B
Total Assets¥ 190.42B¥ 178.22B¥ 171.62B¥ 166.33B¥ 165.18B
Total Debt¥ 3.85B¥ 3.85B¥ 3.85B¥ 3.85B¥ 3.85B
Net Debt¥ -50.24B¥ -40.86B¥ -46.77B¥ -55.71B¥ -57.17B
Total Liabilities¥ 37.78B¥ 30.59B¥ 27.87B¥ 29.49B¥ 26.85B
Stockholders' Equity¥ 152.63B¥ 147.62B¥ 143.75B¥ 136.26B¥ 137.75B
Cash Flow
Free Cash Flow¥ 25.64B¥ -14.07B¥ 716.00M¥ 7.27B¥ 10.35B
Operating Cash Flow¥ 29.78B¥ -11.08B¥ 2.58B¥ 9.25B¥ 13.34B
Investing Cash Flow¥ -19.65B¥ 315.00M¥ -5.85B¥ -2.63B¥ -7.89B
Financing Cash Flow¥ -5.37B¥ -8.84B¥ -5.66B¥ -6.99B¥ -8.13B
Currency in JPY

Kaken Pharmaceutical Co Earnings and Revenue History

Income Statement >

Kaken Pharmaceutical Co Debt to Assets

Balance Sheet >

Kaken Pharmaceutical Co Cash Flow

Cash Flow >

Kaken Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >